Equity Overview
Price & Market Data
Price: $6.40
Daily Change: +$0.03 / 0.47%
Daily Range: $6.37 - $6.45
Market Cap: $412,045,984
Daily Volume: 7,107
Performance Metrics
1 Week: -28.91%
1 Month: -31.21%
3 Months: -45.13%
6 Months: -51.00%
1 Year: -54.04%
YTD: -42.30%
Company Details
Employees: 332
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.